Jubilant Life Sciences has received USFDA approval for Indocin
Jubilant Life Sciences has received final USFDA approval for the generic version of its non-steroidal anti-inflammatory drug, Indocin. The approval for Indomethacin capsules is a […]
Month: November 2017
Ajanta Pharma launches eletriptan hydrobromide in USA
Ajanta Pharma has launched eletriptan hydrobromide tablets in the US market. The drug is a bioequivalent generic version of Relpax tablets and the company has […]
Cadila Healthcare receives USFDA approval for aspirin and extended release dipyridamole capsules
Zydus Cadila has received final USFDA approval to market aspirin and extended release dipyridamole capsules, which is used to prevent excessive blood clotting and reduce […]
Ajanta Pharma receives USFDA approval for Entacapone
Ajanta Pharma has received final USFDA approval for Entacapone tablets to market the same in USA. It is a bioequivalent generic version of Comtan tablets. […]
Lupin receives USFDA approval for Nadolol
Lupin has received final USFDA approval to market generic Nadolol tablets, used for treatment of hypertension, in the American market. The drug will be marketed […]
AstraZeneca receives approval for Xigduo XR tablets in India
AstraZeneca Pharma has received marketing authorisation from the Drug Controller General India DCG(I) for Xigduo XR tablets used in treatment of adults with type II […]
Glenmark Pharma launches Apermilast drug for Psoriasis
Glenmark Pharmaceuticals has launched Apremilast, the first advanced oral systemic treatment for Psoriasis in India. The drug is phosphodiesterase 4 (PDE4) inhibitor indicated for the […]
Alembic Pharma acquires US based West Caldwell
Alembic Pharmaceuticals has acquired a US based generic drug developer West Caldwell, New Jersey. With this acquisition Alembic will now have a total of 69 […]